<DOC>
	<DOCNO>NCT02773316</DOCNO>
	<brief_summary>A study ass bioavailability single dose MR902 ass effect food absorption</brief_summary>
	<brief_title>Study Assess Pharmacokinetic ( PK ) , Bioavailability &amp; Food Effect MR902 Compared With Immediate Release ( IR ) Morphine Sulphate Oral Solution</brief_title>
	<detailed_description>Volunteers receive single dose investigational drug 2 occasion reference drug 1 occasion . Volunteers randomise one two group , group receive different dose strength MR902 fed fast state . The study involve screen visit 21 day first dose 3 overnight stay 3 study period , post-study medical visit . Volunteers receive naltrexone reduce anticipate opioid side effect .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Healthy free significant abnormal finding determine medical history , physical examination , vital sign , laboratory test ECG . Body weight range 55 100 kg BMI ≥ 18.5 ≤ 30.0 . Willing eat food supply throughout study . The subject 's primary care physician confirm within last 12 month first dose nothing medical history would preclude enrolment clinical study . Female subject pregnant lactating . Any history drug alcohol abuse , misuse , physical psychological dependence . Any history condition might interfere drug absorption , distribution , metabolism excretion . Use opioid opioid antagonistcontaining medication past 30 day . Any history frequent nausea vomit regardless etiology . Any history seizures symptomatic head trauma . History respiratory depression , hypoxia elevate carbon dioxide level blood . History paralytic ileus , gastrointestinal disease clinically significant gastrointestinal problem . Participation clinical drug study 90 day precede initial dose study . Any significant illness 4 week precede entry study . Use medication include vitamin , herbal and/or mineral supplement 7 day precede initial dose course study ( exception continue use HRT contraceptive ) . History smoke within 60 day IMP administration refusal abstain smoking study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>